Multiple Myeloma Coverage from Every Angle
ABOUT
SECTIONS
JNCCN Spotlights
Videos
News
Medical Literature
CE Activities
Clinical Trials
For Your Patients
NCCN RESOURCES
NCCN Guidelines
®
NCCN Compendium
®
NCCN Templates
®
NCCN Guidelines for Patients®
360 HUB
Advanced Skin Cancers
CLL/MCL
Multiple Myeloma
Non–Small Cell Lung Cancer
Ovarian Cancer
JNCCN
Editor:
Shaji K. Kumar, MD
Advertisement
Advertisement
JNCCN Spotlights
Teclistamab-cqyv
CAR T-Cell Therapies: Idecabtagene Vicleucel and Ciltacabtagene Autoleucel
Selinexor (Xpovio
®
)
(UPDATE) Daratumumab
Elotuzumab (Empliciti®)
Ixazomib (Ninlaro
®
)
(UPDATE) Ixazomib Update
Carfilzomib (Kyprolis
®
)
(UPDATE) Carfilzomib (Kyprolis)
Daratumumab (Darzalex
®
)
JNCCN Spotlights
?
Teclistamab-cqyv
(UPDATE) Daratumumab
Elotuzumab
View More >
Advertisement
Resources
For your Patients
Copyright ©
2026
National Comprehensive Cancer Network, All Rights Reserved
Bots not welcome here
